Voleon Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Voleon Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$634K	Buy	1,277 +764	+149%	+$339K	0.01%	564
2026 Q1	$229K	Buy	+513	New	+$239K	﹤0.01%	715
2025 Q4	–	Sell	-10,830	Closed	-$4.24M	–	1034
2025 Q3	$4.24M	Buy	10,830 +8,137	+302%	+$3.4M	0.1%	196
2025 Q2	$1.2M	Sell	2,693 -3,060	-53%	-$1.41M	0.07%	224
2025 Q1	$2.79M	Sell	5,753 -7,475	-57%	-$3.48M	0.22%	113
2024 Q4	$5.33M	Buy	+13,228	New	+$6.13M	0.4%	68
2021 Q1	–	Sell	-165,000	Closed	-$39M	–	37
2020 Q4	$39M	Buy	+165,000	New	+$37.9M	4.17%	6
2019 Q4	–	Sell	-44,000	Closed	-$7.45M	–	236
2019 Q3	$7.45M	Buy	+44,000	New	+$7.78M	0.57%	40

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Voleon Capital Management's VRTX Position: Q2 2026 in Review

Voleon Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 149% in Q2 2026, buying an estimated $339K and bringing the position to 1,277 shares worth $634K. The position accounts for 0.01% of the portfolio, ranked #564.

Voleon Capital Management first reported a position in VRTX in Q3 2019 and has held it in 8 quarters since. The position peaked at $39M in Q4 2020. 1,758 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Voleon Capital Management held 1,277 shares of Vertex Pharmaceuticals worth $634K as of Q2 2026.
Voleon Capital Management bought 764 Vertex Pharmaceuticals shares in Q2 2026, an estimated $339K.
Vertex Pharmaceuticals made up 0.01% of Voleon Capital Management's portfolio in Q2 2026, its #564 holding.
Voleon Capital Management first reported a position in Vertex Pharmaceuticals in Q3 2019 and has held it in 8 quarters since.
Voleon Capital Management's Vertex Pharmaceuticals position peaked at $39M in Q4 2020.
1,758 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.